Neil Rosenkranz
Gastroenterology · Miami, FLNPI 1295778173
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 256 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,546 and has fallen 98.8% since, to $18 in 2022.
Across 256 payments — averaging $16.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$876
- Johnson & Johnson$644
- AbbVie$606
- QOL Medical, LLC$465
- Gilead$250
- Intercept Pharmaceuticals, Inc.$200
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,93296%
- Education$1664%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 69 | $876 |
| Johnson & Johnson | 32 | $644 |
| AbbVie(2 entities) | 33 | $606 |
| QOL Medical, LLC | 40 | $465 |
| Gilead | 13 | $250 |
| Intercept Pharmaceuticals, Inc. | 9 | $200 |
| Daiichi Sankyo Inc. | 8 | $159 |
| Ironwood Pharmaceuticals, Inc | 7 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $126 |
| Ferring Pharmaceuticals Inc. | 6 | $107 |
| Redhill Biopharma Inc. | 6 | $82 |
| Bristol Myers Squibb | 4 | $68 |
| Romark Laboratories, LC | 3 | $67 |
| Amgen | 3 | $63 |
| Merck | 3 | $54 |
| Alfasigma USA, Inc. | 3 | $52 |
| Concordia Pharmaceuticals Inc. | 2 | $42 |
| Braintree Laboratories, Inc. | 3 | $39 |
| Janssen Scientific Affairs, LLC | 1 | $20 |
| Vivus LLC | 1 | $19 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
| UCB, Inc. | 1 | $15 |
How this compares
$4,098 in reported general payments places this provider in the 55th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Miami
- Lukasz KwapiszMiami$1.2M
- Joanna LopezMiami$670K
- Jerry MartelMiami$511K
- Andres GelrudMiami$208K
- Maria HernandezMiami$197K
- George SanchezMiami$117K
- Jodie BarkinMiami$101K
- Javier ParraMiami$68K
- Samuel GidayOrlando$2M
- Jennifer Seminerio-DiehlOrlando$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.